ESC Premium Access

Antihypertensive treatment effect on 24h blood pressure variability: pooled individual data analysis of ambulatory blood pressure monitoring studies based on olmesartan mono or combination treatment

Congress Presentation

About the speaker

Professor Stefano Omboni

Italian Institute of Telemedicine, Solbiate Arno (Italy)
2 presentations
0 follower

6 more presentations in this session

Combination of valsartan/amlodipine is more effective than bisoprolol/hydrochlorothiazide on reduction of blood pressure variability in patients with moderate or severe hypertension after control

Speaker: Professor S. Shehata (El-Minya, EG)

Thumbnail

Six-year trends in antihypertensive monotherapy: focus on blood pressure control and originals/generics ratio

Speaker: Professor A. Konradi (Saint Petersburg, RU)

Thumbnail

Which is the best choice? One year persistence of ramipril, ramipril/amlodipin free and fixed dose combination therapy in hypertension

Speaker: Doctor G. Simonyi (Budapest, HU)

Thumbnail

Effect of antihypertensive treatment with indapamide on bone metabolism in patients with arterial hypertension and osteoarthritis

Speaker: Mrs K. Simbirtseva (Kyiv, UA)

Thumbnail

Large number of real world evidence studies confirmed effectiveness and safety in treatment with Val/Aml and Val/Aml/HCT worldwide across various ethical groups, disease severities and co-morbidities

Speaker: Doctor K. Stricker (Basel, CH)

Thumbnail

Access the full session

Poster session 2 - Hypertension drug treatment

Speakers: Professor S. Omboni, Professor S. Shehata, Professor A. Konradi, Doctor G. Simonyi, Mrs K. Simbirtseva...
Thumbnail

About the event

Image

ESC Congress 2017

26 August - 30 August 2017

Sessions Presentations

ESC 365 is supported by

logo Novo Nordisk
logo Bristol Myers Squibb